undamentalytics Newsletter
Sign in

Fractyl Health, Inc. (GUTS) stock

Add to watchlist

Add holding +

NASDAQ: GUTS Nasdaq Health Care Equipment Next results ~November 11, 2026

Fractyl Health, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders5 buying, 0 selling7 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds30 adding, 34 cuttingOf 13 active managers that changed their stake, 5 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Next results ~November 11, 2026 (estimated)

Current signal Results well ahead of expectations: Reported earnings per share beat the analysts' consensus estimate by 14% in the quarter to 2026-06-30, the 3rd beat in the last four quarters.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Fractyl Health, Inc.'s latest figures clears our strength thresholds.

Things to watch

  • Volatile shares. Over the past year the shares showed annualised volatility of 132% and a beta of 2.3 against the S&P 500.

Latest results

Earnings per share
-$1.41 against an average estimate of -$1.64: beat by 13.9%
Share reaction
+0.3% in the first session after the results on August 10, 2026, against -0.3% for the S&P 500
Next report
November 11, 2026; average EPS estimate -$1.59

Fractyl Health's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-3.5%
  • 1 week-11.9%
  • 1 month-80.7%
  • This year-96.4%
  • 1 year-93.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Earnings

Last results
August 10, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Announcement
  3. Governance
  4. Shareholder vote
  5. Results
  6. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Fractyl Health, Inc. valuation models and calculator

No model value for Fractyl Health, Inc. at the moment. Current status: limited reported history: available models are shown without a Buy/Hold/Sell rating. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 11, 2026, after the close. Analysts expect revenue of $0 and EPS of −$1.59 (range −$1.68 to −$1.38) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$3.92 +83% — 0%
Next −$3.62 +8% $1m 0%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −16.3% on 90 days ago. In the last 30 days, 0 analysts raised Fractyl Health, Inc.'s forecast and 2 cut it.

Consensus EPS forecast Fractyl Health, Inc., last 90 days
−$6.00 −$4.00 −$2.00 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$4.68 Current fiscal year, 60 days ago: −$3.96 Current fiscal year, 30 days ago: −$3.96 Current fiscal year, 7 days ago: −$3.67 Current fiscal year, Now: −$3.92 −$3.92 Next fiscal year, 90 days ago: −$5.98 Next fiscal year, 60 days ago: −$5.26 Next fiscal year, 30 days ago: −$4.94 Next fiscal year, 7 days ago: −$3.94 Next fiscal year, Now: −$3.62 −$3.62

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$4.68−$5.98
60 days ago −$3.96−$5.26
30 days ago −$3.96−$4.94
7 days ago −$3.67−$3.94
Now −$3.92−$3.62

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$1.64 −$1.41 +13.9%
Mar 2026 −$1.92 −$1.53 +20.2%
Dec 2025 −$2.16 −$0.84 +61.1%
Sept 2025 −$3.79 −$8.52 −124.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

6 analysts, Oct 2026
Buy6100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202666
  2. Sep 2026617
  3. Aug 2026617
  4. Jul 2026617

Counts of recommendations published by analysts covering Fractyl Health, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
2.1%
of tradable shares
Days to cover
1.44
at average volume
Short interest, 1 month
+18%
to October 15, 2026
Held by institutions
53%
of shares
Held by insiders
1.5%
of shares
Employees
100
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 20252026 to date
Return
GUTS+7%−96%
Industry peers (median)−16%−13%
S&P 500+18%+11%
Months that ended higher
GUTS50%36%
S&P 50075%46%
Largest fall from a high during the year
GUTS−69%−97%
S&P 500−19%−9%

Worst fall since February 2, 2024: 99% from February 2, 2024 to October 27, 2026. Getting back needed a 17423% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.88 – $28.44
From 52-week high
−96.7%
vs 50-day average
−82.2%
vs 200-day average
−87.9%
Volatility (1 year)
132%
Beta vs S&P 500
2.34

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±7.5%
After a week
8 up, 4 down
typical move ±11.5%
After a month
5 up, 7 down
typical move ±27.8%
Results releasedNext dayS&P 500 next day5 days21 days
August 10, 2026 +0.3% −0.3% −5.7% −8.6%
May 12, 2026 +23.3% +0.4% +6.2% −5.9%
March 24, 2026 +12.1% +0.2% +2.7% +30.3%
January 5, 2026 −11.1% +1.3% −11.1% −81.1%
November 12, 2025 +1.8% −1.6% +20.9% +103.6%
August 12, 2025 +3.4% +1.4% +1.4% +4.4%
May 13, 2025 −10.2% +0.8% +22.8% +26.9%
March 3, 2025 −3.8% −2.9% −8.3% −28.8%
November 12, 2024 −5.6% −0.3% −12.7% −12.2%
August 14, 2024 +2.2% +2.0% +30.4% +21.3%
May 13, 2024 +6.9% +0.5% +12.6% −1.5%
April 1, 2024 −8.9% −0.8% +3.2% −8.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms . Generated November 3, 2026. Definitions in our methodology.

Who owns it

Funds buying and selling
Reported value
$65.2M
Institutions reporting
75
Shares held vs prior quarter
▲ 14.0%
Positions opened / closed
12 / 18

Top buyers and sellers, Q2 2026: 30 institutions bought and 34 sold ; the biggest buyer was Nantahala Capital Management, LLC (+9.2M shares) and the biggest seller 683 Capital Management, LLC (−6.0M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Nantahala Capital Management, LLC $17.9M 22.6M 27.5% ▲ 68.9%
Catalio Capital Management, LP $4.9M 6.2M 7.5% ▲ 12.3%
Vanguard Capital Management LLC $4.8M 6.1M 7.4% ▲ 10.2%
Bank Of America Corp $4.8M 6.0M 7.3% ▲ 4727.7%
Pale Fire Capital Se $4M 5.0M 6.1% ▼ 15.5%
General Catalyst Group Management, LLC $3.9M 4.9M 5.9% 0.0%
Deer Management Co. LLC $3.8M 4.8M 5.8% 0.0%
Maverick Capital Ltd $3.2M 4.0M 4.8% 0.0%
M28 Capital Management LP $1.5M 1.9M 2.3% 0.0%
Blackrock, Inc. $1.4M 1.8M 2.2% ▼ 15.8%
Woodline Partners LP $1.4M 1.8M 2.2% ▼ 20.4%
Jane Street Group, LLC $1.4M 1.7M 2.1% ▲ 4260.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Fractyl Health, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $187,149 7 trades by 5 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $187,149 net buying
Insider Date Trade Shares Price Value
Bradley William Director September 14, 2026 Buy 64,516 $0.62 $40,000
Royan Ajay Director June 12, 2026 Buy 23,000 $0.85 $19,550
Rajagopalan Harith Chief Executive Officer June 10, 2026 Buy 25,000 $0.73 $18,250
Sheffield Ian Director June 10, 2026 Buy 35,000 $0.73 $25,550
Bradley William Director June 10, 2026 Buy 68,493 $0.73 $50,000
Smith Weber Lara Chief Financial Officer June 8, 2026 Buy 20,000 $0.69 $13,800
Rajagopalan Harith Chief Executive Officer December 4, 2025 Buy 10,416 $1.92 $19,999

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 2, 2026 estimated from the company's past filing pattern, not announced

  • August 10, 2026
  • May 12, 2026
  • March 24, 2026
  • January 5, 2026
  • November 12, 2025
  • August 12, 2025

Recent SEC filings

Data status

When each part of this page on Fractyl Health, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Fractyl Health, Inc. in brief

What does Fractyl Health, Inc. do?
Fractyl Health, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Fractyl Health, Inc.'s stock ticker?
Fractyl Health, Inc. trades under the ticker GUTS on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
Who are Fractyl Health, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Nantahala Capital Management, LLC, Catalio Capital Management, LP and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Are insiders buying or selling Fractyl Health, Inc. stock?
Over the last 12 months, Fractyl Health, Inc.'s directors and officers reported 7 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Fractyl Health, Inc.'s next earnings date?
Around November 11, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Fractyl Health, Inc. announces its own schedule.